LLC NVP "Mikrokhim" (responsible for batch release, excluding batch control/testing; production unit (all stages of the production process))
UkraineAll drugs from this manufacturer
-
It is indicated for the secondary prevention of cardiovascular complications in adults whose condition is adequately controlled with appropriate doses of rosuvastatin and acetylsalicylic acid.
Dosage form: capsules, hard
Active substance Dosage acetylsalicylic acid 75 mg rosuvastatin 5 mg ATC: C10BX05
-
The drug is intended for the secondary prevention of cardiovascular complications in adult patients whose condition is adequately controlled with appropriate doses of rosuvastatin and acetylsalicylic acid.
Dosage form: capsules, hard
Active substance Dosage acetylsalicylic acid 75 mg rosuvastatin 10 mg ATC: C10BX05
-
The drug is indicated for the secondary prevention of cardiovascular complications in adults whose condition is adequately controlled with appropriate doses of rosuvastatin and acetylsalicylic acid.
Dosage form: capsules, hard
Active substance Dosage acetylsalicylic acid 75 mg rosuvastatin 20 mg ATC: C10BX05